Bone marrow nonneoplastic

Alterations in cellularity

Amegakaryocytosis



Last author update: 1 March 2013
Last staff update: 2 October 2023

Copyright: 2002-2024, PathologyOutlines.com, Inc.

PubMed Search: Bone marrow amegakaryocytic thrombocytopenia

Dragos C. Luca, M.D.
Page views in 2023: 447
Page views in 2024 to date: 115
Cite this page: Luca DC. Amegakaryocytosis. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/bonemarrowamegakaryocyticthrombocytopenia.html. Accessed March 28th, 2024.
Amegakaryocytic thrombocytopenia
Definition / general
  • Also called CAMT (congenital amegakaryocytic thrombocytopenia)
  • Extremely rare, usually diagnosed in early childhood (Pediatr Blood Cancer 2011;57:199, Hematol Oncol Clin North Am 2009;23:321)
  • Initially thought to have variable inheritance (autosomal recessive or X linked) but X linked forms now reinterpreted as mild or attenuated forms of Wiskott-Aldrich syndrome


Etiology


Clinical features and diagnosis
  • Isolated nonimmune thrombocytopenia with decreased marrow megakaryocytes and high serum TPO levels
  • Red cell macrocytosis with normal hemoglobin level
  • Bone marrow initially normocellular
  • Mucocutaneous or GI bleeding, variable physical abnormalities (Br J Haematol 2005;131:636)


Case reports


Treatment and prognosis
  • Stem cell transplantation
  • 50% evolve to aplastic anemia (at mean age 3.5 years); may evolve to myelodysplastic syndrome or leukemia


Microscopic (histologic) images

Images hosted on other servers:
Bone marrow aspiration and trephine biopsy

Bone marrow aspiration and trephine biopsy

Bone marrow failure in child

Bone marrow failure in child

Congenital
[Pending]
Secondary
[Pending]
Back to top
Image 01 Image 02